
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Los Angeles - Azathioprine is an effective treatment for severe atopic dermatitis in adults, although it can be poorly tolerated by some patients due to gastrointestinal side effects, and careful laboratory monitoring is indicated because of its potential to cause hematologic and hepatic toxicity, according to results of a randomized, double-blind, placebo-controlled, crossover study.